Skip to main content
Clinical Trials/CTRI/2011/08/001965
CTRI/2011/08/001965
Completed
Phase 4

A single-blind randomized controlled clinical study comparing the efficacy, tolerability and safety of levocetrizine and olopatadine in chronic urticaria - ESLO

Burdwan Medical College and Hospital0 sites120 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: null- Chronic Urticaria
Sponsor
Burdwan Medical College and Hospital
Enrollment
120
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Burdwan Medical College and Hospital

Eligibility Criteria

Inclusion Criteria

  • 1\. Age above 18 years
  • 2\. Patients of either sex
  • 3\. Patients suffering from urticaria for more than 6 weeks

Exclusion Criteria

  • 1Pregnant or nursing women
  • 2End stage renal disease
  • 3Patients having immunosuppression due to drug or disease
  • 4History of alcohol or substance abuse
  • 5Subjects working in night\-shifts or are likely to change the usual sleep/wake cycle.
  • 6Patients driving automobiles.
  • 7Participation in any other clinical trial within past 3 months
  • 8Patients unwilling to provide written informed consent or unlikely to comply with the trial protocol
  • 9Any other condition, which in the opinion of the investigators, is not conducive to inclusion of the subject in the trial

Outcomes

Primary Outcomes

Not specified

Similar Trials